Victor Aboyans։ Think About Lipids in VTE
Victor Aboyans, Head of Department at Centre Hospitalier Princesse Grace, shared Christian Heiss’s post on LinkedIn, adding:
”Happy to share this collaborative document.
Think about lipids in VTE.”
Christian Heiss, Associate Head of Medical School (Research and Innovation) at the University of Surrey, Professor and NHS Consultant in Interventional Cardiovascular Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:
”Very pleased to see our ESC/ESVM clinical consensus statement published in the European Journal of Preventive Cardiology.
VTE is traditionally viewed through the lens of anticoagulation — rightly so.
But VTE also shares important risk factors with atherosclerotic cardiovascular disease, and lipid levels are part of routine cardiovascular risk assessment.
This statement reviews the evidence for lipid-lowering therapy in primary and secondary VTE prevention, and highlights where data are still needed.
The key message for me: vascular prevention increasingly needs to think across arterial and venous disease — not in silos.”
Title: Lipid-lowering therapy in venous thromboembolism: A Clinical Consensus Statement of the ESC Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function, and the European Society of Vascular Medicine (ESVM)
Authors: Christine Espinola-Klein, Christian Heiss, Marianne Brodmann, Thomas Gary, Lucia Mazzolai, Alessandra Bura-Riviere, Birgit Linnemann, Victor Aboyans, José F Rodriguez Palomares, Frederikus A Klok, Heinz Drexel, Jill Belch, Mislav Vrsalovic, Oliver Schlager
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 15, 2026, 18:26Chanakya Nayudu: Presenting My Research at ISTH Congress 2026 in Paris
-
Oct 15, 2026, 18:09Maha Othman: Students Lead World Thrombosis Day 2026 Awareness Events
-
Oct 15, 2026, 17:52Jill de Mol։ Rapamycin Modulates Immune Responses in Aged Atherosclerosis
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms
-
Oct 15, 2026, 16:26Hauke Horstmann: Can an Existing Drug Be Repurposed to Treat Atherosclerosis?
-
Oct 15, 2026, 15:19Bernadette Borrelli: AdventHealth Teams Unite to Mark World Thrombosis Day
-
Oct 15, 2026, 15:03Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome
-
Oct 15, 2026, 14:34Marium Khan: New Systematic Review Examines Asundexian Safety and Efficacy in Cardiovascular Disease
-
Oct 15, 2026, 14:03JTH Research Recap Explores Occult Malignancy Screening in DVT